Entries by connective

Statement on calling an Extraordinary General Meeting

Cambridge, UK / Waltham, MA: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting (the “EGM”). The Company is reviewing the notice […]

Statement on potential Extraordinary General Meeting

Cambridge, UK/ Waltham, MA: Abcam plc (Nasdaq: ABCM), (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today notes that its founder and former director Dr. Jonathan Milner has indicated he will take steps to call an extraordinary general meeting (“EGM”) of the Company’s shareholders to elect himself […]

Result of Annual General Meeting

Cambridge, UK/ Waltham, MA: Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting (the “AGM”) held today.  A total of 196,862,506 shares representing 85.7% of Abcam’s issued and outstanding voting capital (including withheld) were voted in connection with the meeting. […]

Business Update

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following updates. As part of the five-year strategy set out in 2019, focusing on generating durable revenue growth, the Company invested to remove scalability constraints through critical investments in its people, processes, […]

Comments on Investor Engagement

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes the Form 13D filed today by founder and former director Dr Jonathan Milner and related press reports. The Company meets with Dr Milner with some regularity, including most recently on Friday, April 28, 2023. […]

Upcoming Abcam Investor Events

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the following investor events. Michael Baldock, Chief Financial Officer, will present at two upcoming investor conferences Bank of America 2023 Health Care Conference on Tuesday, May 9 at 10:40am PDT William Blair’s 43rd […]

Trading Update

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the quarter ending 31 March 2023. First Quarter 2023 Period Estimated Reported Revenue Estimated Adjusted Operating Profit % First Quarter 2023 >£100 million >25% On a constant […]

Lunaphore and abcam announce agreement for primary antibody validation for use on COMET™, combining power of trusted antibody provider with superior multiplex capabilities

  LAUSANNE, Switzerland and CAMBRIDGE, UK – April 06, 2023 – 5:00 pm (CEST) – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ: ABCM), a global life science company working together with researchers to advance science and enable faster breakthroughs, today announced an agreement to […]